Skip to content
← Compound profiles
Image for the Phytotherapy compound group
Phytotherapy

Beta-glucans

Beta-1,3/1,6-glucans

Mechanism

Beta-glucans are cell-wall polysaccharides from yeast (Saccharomyces cerevisiae), oats/grains and mushrooms. Beta-1,3/1,6-glucans from yeast are recognized via receptors of innate immune cells (e.g. Dectin-1) and modulate functions such as phagocytosis, complement and macrophage activity in vitro and in animal models; grain-derived beta-glucans additionally act as soluble fiber. In the horse, individual works point to immunomodulating effects (e.g. improved hemolytic complement activity after oral administration, modulation of the response to an endotoxemic stimulus). Overall the equine evidence is limited and heterogeneous; clinical endpoints are only insufficiently studied.

Cautions

  • · Immunomodulating — critically discussed in autoimmune/immune disorders, consult a veterinarian
  • · Equine evidence limited and heterogeneous; clinical endpoints barely demonstrated

Sources

PMID:34083928Picetti et al. 2021 (Vet World) — orales Beta-Glucan verbessert hämolytische Komplementaktivität beim Pferd
PMID:38338117Lacerenza et al. 2024 (Animals) — Beta-Glucan-Supplementierung bei LPS-induzierter Endotoxämie beim Pferd
VO 767/2009Futtermittel-VO (EG) 767/2009 — Kennzeichnung Ergänzungsfutter

Usage note

This content is for information and education. It does not replace veterinary diagnosis or treatment. If your horse shows signs of illness, consult a veterinarian.

“Nothing forced can ever be beautiful.”
Xenophon · On Horsemanship (c. 365 BC)

Equiterna is an intermediary platform for equine knowledge, marketplace and tools — not a veterinary-medicines dealer, veterinary practice or pharmacy. Compound information is study-attributed and free of healing claims. Legal framework: Regulation (EU) 2019/6 / TAMG (DE/AT), Feed Regulation (EC) 767/2009, FEI Prohibited Substances List, HWG.